Morristown-based Sanofi will be the latest U.S drugmaker to inject billions of dollars into domestic operations and American manufacturing.

Nippon Steel plans to invest $14 billion in U.S. Steel's operations including up to $4 billion in a new steel mill if the ...

Sanofi SA said it will invest at least $20 billion in the US through 2030, joining other European pharmaceutical companies ...

The Taiwanese chip-materials maker plans to further grow its U.S. presence, in line with the Trump administration’s efforts to boost manufacturing.

Sanofi plans to invest at least $20 billion in the United States through 2030 to boost manufacturing and research, joining ...

Sanofi plans to invest $20 billion in U.S.-based drug R&D and manufacturing over five years, creating jobs and boosting ...

A federal jury in Santa Ana has ordered Johnson & Johnson (NYSE:JNJ) to pay $147 million after its Biosense Webster unit was ...

Add Sanofi to the list of drugmakers committing billions to bolster their operations in the United States as President Donald ...

J&J has embarked on a reshoring drive with a pledge to invest $55 billion in the next four years within the US, with four new manufacturing facilities at the heart of the plan. The announcement ...

Johnson & Johnson’s Kenvue – previously the planned New Consumer Health Company – is just one part of the 135-year old company’s plan to reinvigorate its corporate image. The name "Kenvue ...

The proposed sale of ADT Alarms is in line with Johnson Controls' plans to review its strategy ... including Elliott Investment Management, which owns a large stake in Johnson Controls worth more than ...